Phase II study of esorubicin (4?-deozydoxorubicin) in advanced epithelial carcinoma of the ovary: A Gynecologic Oncology Group study

Oncology Group ◽

Oncology Group Study ◽

Carcinoma Of The Ovary

Phase II Study of Ifosfamide and Mesna in Nonsquamous Carcinoma of the Cervix: A Gynecologic Oncology Group Study

Gynecologic Oncology ◽

10.1006/gyno.1993.1084 ◽

1993 ◽

Vol 49 (1) ◽

pp. 48-50 ◽

Cited By ~ 25

Author(s):

Gregory P. Sutton ◽

John A. Blessing ◽

Philip J. DiSaia ◽

William P. McGuire

Keyword(s):

Phase Ii ◽

Phase Ii Study ◽

Gynecologic Oncology ◽

Oncology Group ◽

Phase II study of oxaliplatin as second-line chemotherapy in endometrial carcinoma: A Gynecologic Oncology Group study

Gynecologic Oncology ◽

10.1016/j.ygyno.2006.03.043 ◽

2006 ◽

Vol 103 (2) ◽

pp. 523-526 ◽

Cited By ~ 30

Author(s):

Paula M. Fracasso ◽

John A. Blessing ◽

Kelly L. Molpus ◽

Lisa M. Adler ◽

Joel I. Sorosky ◽

...

Keyword(s):

Endometrial Carcinoma ◽

Phase Ii ◽

Phase Ii Study ◽

Gynecologic Oncology ◽

Second Line ◽

Oncology Group ◽

Oncology Group Study ◽

Second Line Chemotherapy ◽

Line Chemotherapy

Phase II trial of piperazinedione (NSC 135758) in the treatment of advanced or recurrent carcinoma of the ovary A Gynecologic Oncology Group study

American Journal of Clinical Oncology ◽

10.1097/00000421-198406000-00012 ◽

1984 ◽

Vol 7 (3) ◽

pp. 261-264 ◽

Cited By ~ 1

Author(s):

J. Tate Thigpen ◽

John A. Blessing ◽

James C. Arseneau ◽

Howard D. Homesley

Keyword(s):

Phase Ii ◽

Phase Ii Trial ◽

Gynecologic Oncology ◽

Oncology Group ◽

Oncology Group Study ◽

Recurrent Carcinoma ◽

Carcinoma Of The Ovary

2A phase II study to determine the response to second curettage as initial management for persistent “low-risk” non-metastatic gestational trophoblastic neoplasia: A Gynecologic Oncology Group study

Gynecologic Oncology ◽

10.1016/j.ygyno.2014.07.079 ◽

2014 ◽

Vol 134 (2) ◽

pp. 438-439 ◽

Cited By ~ 1

Author(s):

R.J. Osborne ◽

V.L. Filiaci ◽

R.S. Mannel ◽

S.A. Davidson ◽

J.S. Hoffman ◽

...

Keyword(s):

Phase Ii ◽

Phase Ii Study ◽

Gynecologic Oncology ◽

Low Risk ◽

Gestational Trophoblastic Neoplasia ◽

Oncology Group ◽

Initial Management ◽

A Phase II Study of Topotecan in Patients with Squamous Cell Carcinoma of the Cervix: A Gynecologic Oncology Group Study

Gynecologic Oncology ◽

10.1006/gyno.2000.6024 ◽

2001 ◽

Vol 81 (2) ◽

pp. 213-215 ◽

Cited By ~ 78

Author(s):

Laila I. Muderspach ◽

John A. Blessing ◽

Charles Levenback ◽

James L. Moore

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Phase Ii ◽

Squamous Cell ◽

Phase Ii Study ◽

Gynecologic Oncology ◽

Oncology Group ◽

Phase II study of maytansine in the treatment of advanced or recurrent adenocarcinoma of the ovary A Gynecologic Oncology Group Study

American Journal of Clinical Oncology ◽

10.1097/00000421-198306000-00003 ◽

1983 ◽

Vol 6 (3) ◽

pp. 273-276 ◽

Cited By ~ 16

Author(s):

J. Tate Thigpen ◽

Clarence E. Ehrlich ◽

William T. Creasman ◽

Stephen Curry ◽

John A. Blessing

Keyword(s):

Phase Ii ◽

Phase Ii Study ◽

Gynecologic Oncology ◽

Oncology Group ◽

Oncology Group Study ◽

Adenocarcinoma Of The Ovary

A phase II study of neoadjuvant chemotherapy plus durvalumab and tremelimumab in advanced-stage ovarian cancer: a Korean Gynecologic Oncology Group Study (KGOG 3046), TRU-D

Journal of Gynecologic Oncology ◽

10.3802/jgo.2019.30.e112 ◽

2019 ◽

Vol 30 (6) ◽

Cited By ~ 2

Author(s):

Jung-Yun Lee ◽

Jae Weon Kim ◽

Myong Cheol Lim ◽

Sunghoon Kim ◽

Hee Seung Kim ◽

...

Keyword(s):

Ovarian Cancer ◽

Neoadjuvant Chemotherapy ◽

Phase Ii ◽

Phase Ii Study ◽

Gynecologic Oncology ◽

Advanced Stage ◽

Oncology Group ◽

Tumor mutational analysis of GOG248, a phase II study of temsirolimus or temsirolimus and alternating megestrol acetate and tamoxifen for advanced endometrial cancer (EC): An NRG Oncology/Gynecologic Oncology Group study.

Journal of Clinical Oncology ◽

10.1200/jco.2015.33.15_suppl.5592 ◽

2015 ◽

Vol 33 (15_suppl) ◽

pp. 5592-5592 ◽

Cited By ~ 2

Author(s):

Andrea P. Myers ◽

Virginia L. Filiaci ◽

Yuping Zhang ◽

Michael Pearl ◽

Kian Behbakht ◽

...

Keyword(s):

Endometrial Cancer ◽

Phase Ii ◽

Mutational Analysis ◽

Phase Ii Study ◽

Gynecologic Oncology ◽

Megestrol Acetate ◽

Oncology Group ◽

A phase II study of two topotecan regimens evaluated in recurrent platinum-sensitive ovarian, fallopian tube or primary peritoneal cancer: A Gynecologic Oncology Group Study (GOG 146Q)

Yearbook of Oncology ◽

10.1016/j.yonc.2011.07.016 ◽

2011 ◽

Vol 2011 ◽

pp. 74-75

Author(s):

J.T. Thigpen

Keyword(s):

Fallopian Tube ◽

Phase Ii ◽

Phase Ii Study ◽

Gynecologic Oncology ◽

Oncology Group ◽

Oncology Group Study ◽

Primary Peritoneal Cancer ◽

Peritoneal Cancer ◽

Platinum Sensitive

A phase II study of two topotecan regimens evaluated in recurrent platinum-sensitive ovarian, fallopian tube or primary peritoneal cancer: a Gynecologic Oncology Group Study (GOG 146Q)

Yearbook of Medicine ◽

10.1016/s0084-3873(11)00207-0 ◽

2011 ◽

Vol 2011 ◽

pp. 154-155

Author(s):

J.T. Thigpen

Keyword(s):

Fallopian Tube ◽

Phase Ii ◽

Phase Ii Study ◽

Gynecologic Oncology ◽

Oncology Group ◽

Oncology Group Study ◽

Primary Peritoneal Cancer ◽

Peritoneal Cancer ◽

Platinum Sensitive